insights_auto
Nega BOT tushdi 20,00%?
Batafsil oʻrganishchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080Â A$
arrow_downward
-20,00%(-0,0020) 1K
20-noy, 16:10:07 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01Â A$
Yuqori
0,01Â A$
Past
0,01Â A$
Bozor kapitali
22,10Â mln
Oʻrtacha hajm
11,07Â mln
Hajmi
8,60Â mln
52 haftalik eng yuqori
0,15Â A$
52 haftalik eng past
0,01Â A$
Aksiya boʻyicha daromad
-0,03Â A$
Muomaladagi aksiyalar
2,76Â mlrd
Xodimlar soni
11
Ochish
0,01Â A$
Yuqori
0,01Â A$
Past
0,01Â A$
Bozor kapitali
22,10Â mln
Oʻrtacha hajm
11,07Â mln
Hajmi
8,60Â mln
52 haftalik eng yuqori
0,15Â A$
52 haftalik eng past
0,01Â A$
Aksiya boʻyicha daromad
-0,03Â A$
Muomaladagi aksiyalar
2,76Â mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AP News
·
11 soat oldin
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Trefis
·
1 soat oldin
25 S&P 500 Stocks Just Made New 52-Week Lows
Yahoo Finance
·
13 soat oldin
Wall St ends sharply lower on AI selloff, S&P 500, Dow in correction
ABC News - Breaking News, Latest News and Videos
·
1 kun oldin
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year as rout in tech stocks tanks the market
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida